EtDO-P4 is a potent and specific inhibitor of the cerebroside synthase. References: Fedoryszak-Kuska N, Panasiewicz M, Domek H, Pacuszka T. Glucosylceramide synthase inhibitors D-PDMP and D-EtDO-P4 decrease the GM3 ganglioside level, differ in their effects on insulin receptor autophosphorylation but increase Akt1 kinase phosphorylation in human hepatoma HepG2 cells. Acta Biochim Pol. 2016;63(2):247-51. doi: 10.18388/abp.2014_930. Epub 2016 May 12. PubMed PMID: 27172362.

纯度：≥98%

CAS：245329-78-6